 BRANFORD, Conn. and NESS ZIONA, Israel, Sept. 02, 2021 GLOBE NEWSWIRE -- BiomX Inc. NYSE American: PHGE BiomX or the Company, a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced Jonathan Solomon, Chief Executive Officer, will be presenting at three upcoming virtual investor events in September. 